ASCO喉癌喉保留策略指南更新
美国临床肿瘤学会专家小组更新2005年1月至2017年5月文献,确认对合适选择的喉癌患者采用喉保留策略不损害生存,各喉保留方案与全喉切除加辅助治疗相比无生存优势。更新支持对局限期(T1、T2)患者行内镜手术切除、对T4a或严重治疗前喉功能障碍患者初始全喉切除,并新增治疗后PET评估区域淋巴结及嗓音吞咽功能评价建议。
要点
- T1、T2喉癌初始治疗可选内镜切除或放疗,两者结局相似。
- 局部晚期T3、T4可选器官保留手术、放化疗或单纯放疗,不损害总生存。
- 广泛T3或大T4a且喉功能差者,全喉切除可能获更好生存和生活质量。
核心结论
- 对合适选择的喉癌患者,喉保留策略不损害生存。
- 各喉保留方案与全喉切除加辅助治疗相比均无生存优势。
研究设计与样本
- 美国临床肿瘤学会专家小组对2005年1月至2017年5月文献进行系统评价更新。
主要发现
- T1、T2喉癌采用内镜切除或放疗初始喉保留,结局相似。
- 局部晚期T3、T4可采用器官保留手术、放化疗或单纯放疗,不损害总生存。
- 广泛T3或大T4a病变和/或治疗前喉功能差者,全喉切除可能获得更好生存率和生活质量。
关键数值与推荐
- T1、T2喉癌初始治疗推荐内镜切除或放疗,以保留喉为目的。
- 局部晚期T3、T4可选器官保留手术、放化疗或单纯放疗。
- 临床区域淋巴结阳性(N+)者放化疗后临床和影像完全缓解,不需择期颈清扫。
- 所有患者治疗前应评估嗓音和吞咽功能并接受相关咨询。
临床怎么用
- 对T1、T2喉癌优先考虑内镜切除或放疗以保留喉。
- 局部晚期患者根据病变范围和喉功能选择器官保留策略或全喉切除。
- N+患者放化疗后影像完全缓解可省略择期颈清扫。
- 治疗前常规评估嗓音吞咽功能并咨询治疗对生活质量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose To update the guideline recommendations on the use of larynx-preservation strategies in the treatment of laryngeal cancer. Methods An Expert Panel updated the systematic review of the literature for the period from January 2005 to May 2017. Results The panel confirmed that the use of a larynx-preservation approach for appropriately selected patients does not compromise survival. No larynx-preservation approach offered a survival advantage compared with total laryngectomy and adjuvant therapy as indicated. Changes were supported for the use of endoscopic surgical resection in patients with limited disease (T1, T2) and for initial total laryngectomy in patients with T4a disease or with severe pretreatment laryngeal dysfunction. New recommendations for positron emission tomography imaging for the evaluation of regional nodes after treatment and best measures for evaluating voice and swallowing function were added. Recommendations Patients with T1, T2 laryngeal cancer should be treated initially with intent to preserve the larynx by using endoscopic resection or radiation therapy, with either leading to similar outcomes. For patients with locally advanced (T3, T4) disease, organ-preservation surgery, combined chemotherapy and radiation, or radiation alone offer the potential for larynx preservation without compromising overall survival. For selected patients with extensive T3 or large T4a lesions and/or poor pretreatment laryngeal function, better survival rates and quality of life may be achieved with total laryngectomy. Patients with clinically involved regional cervical nodes (N+) who have a complete clinical and radiologic imaging response after chemoradiation do not require elective neck dissection. All patients should undergo a pretreatment baseline assessment of voice and swallowing function and receive counseling with regard to the potential impact of treatment options on voice, swallowing, and quality of life. Additional information is available at www.asco.org/head-neck-cancer-guidelines and www.asco.org/guidelineswiki .
引用
- Forastiere AA, Ismaila N, Lewin JS, et al. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017. PMID: 29172863. doi:10.1200/JCO.2017.75.7385
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。